Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

IM Cannabis (IMCC) EBITDA Margin: 2019-2024

Historic EBITDA Margin for IM Cannabis (IMCC) over the last 6 years, with Dec 2024 value amounting to -24.44%.

  • IM Cannabis' EBITDA Margin fell 2393.00% to -34.84% in Q3 2025 from the same period last year, while for Sep 2025 it was -19.68%, marking a year-over-year decrease of 576.00%. This contributed to the annual value of -24.44% for FY2024, which is 220.00% down from last year.
  • Per IM Cannabis' latest filing, its EBITDA Margin stood at -24.44% for FY2024, which was down 9.91% from -22.24% recorded in FY2023.
  • IM Cannabis' 5-year EBITDA Margin high stood at -22.24% for FY2023, and its period low was -174.60% during FY2020.
  • Over the past 3 years, IM Cannabis' median EBITDA Margin value was -24.44% (recorded in 2024), while the average stood at -34.45%.
  • In the last 5 years, IM Cannabis' EBITDA Margin crashed by 27,884bps in 2020 and then soared by 12,436bps in 2021.
  • Yearly analysis of 5 years shows IM Cannabis' EBITDA Margin stood at -174.60% in 2020, then soared by 12,436bps to -50.24% in 2021, then tumbled by 643bps to -56.67% in 2022, then surged by 3,443bps to -22.24% in 2023, then plummeted by 220bps to -24.44% in 2024.